Stethoscope
Industries

Life Sciences Policy

CRA’s policy team provides analysis and insights into global, regional and national policy issues affecting patients, the healthcare system, and the life sciences industry. CRA has a reputation for independence and rigor, benefiting from long standing relationships with most leading life sciences organizations as well as national governments and the European Commission and industry associations. Our specialist team has provided unique policy oversight for the past 20 years delivering high quality, robust analysis in a compelling fashion that is accessible to the target audience, whomever it may be.

Our focus areas

Engagements

  • 01
    Evaluating unintended impacts of the IRA’s Medicare Drug Price Negotiation Program on small and large molecule medicines
    A leading pharmaceutical company sought support from CRA Life Sciences experts in analyzing the patient, health system, and innovation implications of the IRA's
    View engagement
  • 02
    Developing an evidence-based framework for sustainable NCCP funding and address global disparities in implementation and outcomes
    A leading pharmaceutical company sought CRA Life Sciences experts to gain a deeper understanding of how governments plan and finance national cancer strategies
    View engagement
  • 03
    Mapping and assessing national impacts of JCAs across Europe
    CRA Life Science experts were retained by a client to provide support on the impact of the EU HTA regulation and the associated JCAs on national HTA systems.
    View engagement

Subscribe to receive our latest Insights.

Subscribe